October 28, 2022 03:12 PM EDTUpdated October 31, 04:52 AM
Pharma
Manufacturing

Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

Tyler Patchen

News Reporter

On­ly a few weeks af­ter the FDA rec­og­nized a short­age of Adder­all, an­oth­er cru­cial drug is in low sup­ply, this time the an­tibi­ot­ic amox­i­cillin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times